Extended Platelet Rich Fibrin in Mandibular Alveolar Ridge Splitting
NCT ID: NCT06637982
Last Updated: 2024-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
32 participants
INTERVENTIONAL
2024-10-10
2025-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Extended Platelet Rich Fibrin in Lateral Sinus Augmentation
NCT06626776
Injectable Platelets Rich Fibrin Versus Hyaluronic Acid for Alveolar Ridge Preservation
NCT05781529
Evaluation of Autogenous Demineralized Dentin Graft for Ridge Preservation With and Without Injectable Platelet Rich Fibrin
NCT05437172
Demineralized Whole-tooth vs Demineralized Particulate Dentin Grafts in Alveolar Ridge Preservation
NCT05336149
Alveolar Ridge Augmentation Following Tooth Extraction Using Bovine Xenograft With Platelet Rich Fibrin Membrane
NCT05791123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ridge splitting with allograft and pericardium membrane
ridge splitting with the use of allograft and pericardium membrane
ridge splitting with the use of allograft and pericardium membrane
ridge splitting with extended platelet rich fibrin
ridge splitting with the use of extended platelet rich fibrin
ridge splitting with the use of extended platelet rich fibrin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ridge splitting with the use of allograft and pericardium membrane
ridge splitting with the use of allograft and pericardium membrane
ridge splitting with the use of extended platelet rich fibrin
ridge splitting with the use of extended platelet rich fibrin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient's cooperation, motivation and good oral hygiene.
* Atrophic posterior mandible of horizontal alveolar dimension range between 3 - 6 mm at the crest, with minimum 10 mm vertical height from the alveolar crest to the superior border of the inferior alveolar canal.
* Absence of undercuts in buccal aspect of the ridge.
* Favorable occlusion and no parafunctional habits.
* Patients able to comply with the required recall visits.
* No gender preface in selection of the patients.
* Acceptable inter-arch space for the future prosthesis.
Exclusion Criteria
* Patients with systemic diseases that contra-indicate the surgical procedure such as uncontrolled diabetes mellitus, bleeding disorders, serious osseous disorders, and mental disorders.
* Patient taking drugs that could affect bone healing process as immunosuppressive drugs and bisphosphonates.
* Heavy smoking and alcoholism.
* Parafunctional habits such as bruxism and clenching.
* Signs of acute infection or pus discharge.
* Untreated periodontal disease or bad oral hygiene.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University
Mansoura, Egypt, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
faisal alshammri
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A0302024OS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.